Atherosclerosis : Technologies of Personalized Medicine
The first national conference with international participation, “Fundamental aspects of atherosclerosis: scientific research for improving the technologies of personalized medicine”, was held in Novosibirsk on 15 October, 2021. The purpose of this conference was to disseminate the latest basic and c...
Saved in:
Sonstige: | |
---|---|
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 electronic resource (150 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993544866304498 |
---|---|
ctrlnum |
(CKB)5680000000037596 (oapen)https://directory.doabooks.org/handle/20.500.12854/81147 (EXLCZ)995680000000037596 |
collection |
bib_alma |
record_format |
marc |
spelling |
Ragino, Yuliya I. edt Atherosclerosis Technologies of Personalized Medicine Atherosclerosis Basel MDPI - Multidisciplinary Digital Publishing Institute 2022 1 electronic resource (150 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Open access Unrestricted online access star The first national conference with international participation, “Fundamental aspects of atherosclerosis: scientific research for improving the technologies of personalized medicine”, was held in Novosibirsk on 15 October, 2021. The purpose of this conference was to disseminate the latest basic and clinical findings in the fields of etiology, clinical characteristics, and modern diagnostics and treatments of atherosclerosis among various relevant specialists. The conference was intended for practicing cardiologists, primary care physicians, medical geneticists, and physician–scientists. The conference included plenary sessions, specialty sessions, satellite symposia, an open competition for young scientists. English Medicine bicssc Cardiovascular medicine bicssc metalloproteinases calcification atherosclerosis multiplex assay coronary heart disease aspirin resistance non-sensitivity antiplatelet light transmission aggregometry Plateletworks® familial hypercholesterolemia targeted sequencing technologies multiplex ligation-dependent probe amplification LDLR APOB ABCG5 APOC3 LPL SREBF1 rare variants coronary atherosclerosis ischemic heart disease saturated fatty acids monounsaturated fatty acids polyunsaturated fatty acids oxidative stress superoxide dismutase catalase glutathione peroxidase cumulative LDL-C level prognosis DNA methylation epigenetic age myocardial infarction acute coronary syndrome population nested case-control HAPIEE project HAPIEE study atrial fibrillation arterial hypertension obesity diabetes mellitus aging determinants prevalence Russian population cohort Cox regression analysis adiponectin leptin interleukin-6 epicardial adipose tissue perivascular adipose tissue circulating biochemical markers coronary atherosclerosis presence and severity integrated biomarker (i-BIO) validation visual markers lipoprotein(a) immune cells blood count 3-0365-3528-4 3-0365-3527-6 Ragino, Yuliya I. oth |
language |
English |
format |
eBook |
author2 |
Ragino, Yuliya I. |
author_facet |
Ragino, Yuliya I. |
author2_variant |
y i r yi yir |
author2_role |
Sonstige |
title |
Atherosclerosis Technologies of Personalized Medicine |
spellingShingle |
Atherosclerosis Technologies of Personalized Medicine |
title_sub |
Technologies of Personalized Medicine |
title_full |
Atherosclerosis Technologies of Personalized Medicine |
title_fullStr |
Atherosclerosis Technologies of Personalized Medicine |
title_full_unstemmed |
Atherosclerosis Technologies of Personalized Medicine |
title_auth |
Atherosclerosis Technologies of Personalized Medicine |
title_alt |
Atherosclerosis |
title_new |
Atherosclerosis |
title_sort |
atherosclerosis technologies of personalized medicine |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2022 |
physical |
1 electronic resource (150 p.) |
isbn |
3-0365-3528-4 3-0365-3527-6 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT raginoyuliyai atherosclerosistechnologiesofpersonalizedmedicine AT raginoyuliyai atherosclerosis |
status_str |
n |
ids_txt_mv |
(CKB)5680000000037596 (oapen)https://directory.doabooks.org/handle/20.500.12854/81147 (EXLCZ)995680000000037596 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Atherosclerosis Technologies of Personalized Medicine |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796652272289054721 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03865nam-a2201057z--4500</leader><controlfield tag="001">993544866304498</controlfield><controlfield tag="005">20240320172755.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202205s2022 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5680000000037596</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/81147</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995680000000037596</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ragino, Yuliya I.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Atherosclerosis</subfield><subfield code="b">Technologies of Personalized Medicine</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Atherosclerosis</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (150 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="a">Open access</subfield><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The first national conference with international participation, “Fundamental aspects of atherosclerosis: scientific research for improving the technologies of personalized medicine”, was held in Novosibirsk on 15 October, 2021. The purpose of this conference was to disseminate the latest basic and clinical findings in the fields of etiology, clinical characteristics, and modern diagnostics and treatments of atherosclerosis among various relevant specialists. The conference was intended for practicing cardiologists, primary care physicians, medical geneticists, and physician–scientists. The conference included plenary sessions, specialty sessions, satellite symposia, an open competition for young scientists.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cardiovascular medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metalloproteinases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">calcification</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">atherosclerosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multiplex assay</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">coronary heart disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aspirin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-sensitivity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antiplatelet</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">light transmission aggregometry</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Plateletworks®</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">familial hypercholesterolemia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">targeted sequencing technologies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multiplex ligation-dependent probe amplification</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">LDLR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">APOB</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ABCG5</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">APOC3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">LPL</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SREBF1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rare variants</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">coronary atherosclerosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ischemic heart disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">saturated fatty acids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">monounsaturated fatty acids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polyunsaturated fatty acids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oxidative stress</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">superoxide dismutase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">catalase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glutathione peroxidase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cumulative LDL-C level</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prognosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DNA methylation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epigenetic age</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">myocardial infarction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">acute coronary syndrome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">population</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nested case-control</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HAPIEE project</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HAPIEE study</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">atrial fibrillation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">arterial hypertension</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">obesity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diabetes mellitus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">determinants</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prevalence</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Russian population cohort</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Cox regression analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adiponectin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">leptin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">interleukin-6</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epicardial adipose tissue</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">perivascular adipose tissue</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">circulating biochemical markers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">coronary atherosclerosis presence and severity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">integrated biomarker (i-BIO)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">validation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">visual markers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lipoprotein(a)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune cells blood count</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3528-4</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3527-6</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ragino, Yuliya I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-03-21 05:12:50 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-05-14 21:41:54 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337782410004498&Force_direct=true</subfield><subfield code="Z">5337782410004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337782410004498</subfield></datafield></record></collection> |